Search NASA⌕ Search

Engineering topics

Lee, Peter

Publications and source records attributed to Lee, Peter.

11 records
All sourcesNASA NTRSDOE OSTI
DOE OSTI2025

Multi-technique characterization of iron reduction by an Antarctic Shewanella : an analog system for putative Martian biosignature identification

ABSTRACT Microbes from terrestrial extreme environments enable testing of biosignature production in conditions relevant to astrobiological targets. Mars, which was likely more conducive to life during early warmer and wetter epochs, has inspired missions that search for signs of early life in the surficial rock record, including mineral or organic biosignatures. Microbial iron reduction is a common and ancient metabolism that may have also operated on other rocky celestial bodies. To investigate biosignature production during iron reduction, aShewanellasp. (strain BF02_Schw) isolated from a subglacial discharge known as Blood Falls, Antarctica, was incubated with the electron acceptor ferrihydrite (Fh). Biosignatures associated with Fh reduction were identified using a suite of techniques currently utilized or proposed for Mars missions, including X-ray diffraction and infrared, Mössbauer, and Raman spectroscopy. The biotic origin of features was validated by transcriptional changes observed between treatments with and without Fh and comparison to killed controls. In live treatments, Fh was reduced to magnetite and goethite, both detected in Martian lacustrine basins. Several soluble and volatile metabolites were also detected, including riboflavin and dimethyl sulfide (DMS), which could be astrobiological indicators of active microbial processes. While none of the identified biosignatures individually would serve as definitive proof of life (past or present), detecting concomitant features associated with known terrestrial biotic processes would provide compelling rationale for more targeted life detection missions. Terrestrial extremophiles can support the exploration of astrobiologically relevant microbial processes, validation of life detection instrumentation, and potentially the discovery of new biomarkers. IMPORTANCE Culture-based experiments with terrestrial extremophiles can elucidate biosignatures that may be analogous to those produced under extraterrestrial conditions, and thus inform sampling and technology strategies for future missions. Here, we demonstrate the production of several biosignatures under iron-reducing conditions byShewanellasp. BF02_Schw, originally isolated from an Antarctic analog feature. These biosignatures could be detectable using flight-ready instrumentation. Growth experiments with terrestrial extremophiles can identify biosignatures measurable by current methodologies and inform the development and optimization of techniques for detecting extant or extinct life on other worlds.

Biotechnology & Applied Microbiology↗
DOE OSTI2021

Recommendations for Dose Selection for Adolescent Patients in Relevant Adult Oncology Clinical Trials

Our research supported the dose selection recommendations for adolescents in the US Food and Drug Administration (FDA) Guidance on Inclusion of Adolescent Patients in Adult Oncology Clinical Trials. The FDA Guidance states that for drugs administered as a flat dose in adults and data showing no clinically meaningful effect of body size on drug exposure and toxicity in adults, a minimum body weight threshold may need to be defined to prevent adolescents who have a lower body weight from exceeding adult exposures. Our review of adult population pharmacokinetic analyses of new molecular entities approved for oncology between January 2015 and March 2021 suggested that 40 kg (the approximate median body weight of a 12-year-old) is generally the lower end of the body weight range that has no clinically relevant effect on drug pharmacokinetics or safety. In conclusion, the minimum body weight threshold and selection of an appropriate dose for adolescents in relevant adult oncology clinical trials should ultimately be determined based on available data on pharmacokinetics or pharmacodynamics of the investigational drug with consideration of body size effect on drug exposure, toxicity, and efficacy data (if available), the therapeutic index of the drug, and dose- and exposure-response relationships in adults.

60 APPLIED LIFE SCIENCES↗
DOE OSTI2020

Columnar-to-equiaxed transition in a laser scan for metal additive manufacturing

In laser powder bed fusion additive manufacturing (LPBFAM), different solidification conditions, e.g., thermal gradient and cooling rate, can be achieved by controlling the process parameters, such as laser power and laser speed. Tailoring the behaviour of the columnar to equiaxed transition (CET) of the printed alloy during fabrication can facilitate the production of highly customized microstructures. In this study, effective analytical solutions for both thermal conduction and solidification are employed to model solidifying melt pools. Microstructure textures and solidification conditions are evaluated for numerous combinations of laser power and laser speed under bead-on-plate conditions. This analytical-based high-throughput tool was demonstrated to select specific process parameters that lead to desired microstructures. Two selected process conditions were examined in detail by a highly parallelized microstructural solidification model to reveal both nucleation and grain growth. Both numerical solutions agree well with experiments that are performed based on bead-on-plate conditions, indicating that these numerical models aid evaluation of the nucleation parameters, providing insights for controlling CET during the LPBFAM processing.

Lang, Yuan↗
DOE OSTI2019

Basic Research Needs for High Energy Physics Detector Research & Development: Report of the Office of Science Workshop on Basic Research Needs for HEP Detector Research and Development: December 11-14, 2019

Transformative discovery in science is driven by innovation in technology. Our boldest undertakings in particle physics have at their foundation precision instrumentation. To reveal the profound connections underlying everything we see from the smallest scales to the largest distances in the Universe, to understand its fundamental constituents, and to reveal what is still unknown, we must invent, develop, and deploy advanced instrumentation. Investments in High Energy Physics (HEP) enabled by instrumentation have been richly rewarded with discoveries of the tiny masses of the neutrinos, the origin of mass itself: the enigmatic Higgs boson, and the surprising accelerating expansion of the Universe. What we have learned is remarkable, unexpected, exciting and mysterious; raising many new questions waiting to be answered. The quest to answer them drives innovation that improves the nation's health, wealth, and security, inspiring the public and drawing young people to science. Excellence and innovation come most effectively from diverse teams of people. Success, therefore, depends critically on attracting, engaging, and supporting a diverse cadre of young people to the field, and ensuring an inclusive environment at all levels. The program laid out in the 2014 Particle Physics Projects Prioritization Panel (P5) report "Building for Discovery - A Strategic Plan for U.S. Particle Physics in a Global Context" guides current and near future experiments to exploit these and other discoveries, and the instrumentation innovation they require, to push the frontiers of science into new territory. To explore this territory HEP will soon embark on planning the next generation of experiments. Realizing these experiments will require giant leaps in capabilities beyond the instrumentation of today. Accordingly, now is a pivotal moment to invest in the accelerated development of cost-effective instrumentation with greatly improved sensitivity and performance that will make measurable the unmeasurable, enabling a tool-driven revolution to open the door to future discoveries. Historic scientific opportunities await us, enabled by executing the instrumentation research plan outlined here.

46 INSTRUMENTATION RELATED TO NUCLEAR SCIENCE AND ↗
NASA NTRS2018

Terrestrial Cardiovascular Coronary Artery Disease (CAD) Screening, Treatment and Risk Mitigation - Lessons Learned from Space Medicine

The Bellagio II Summit sought to correlate current ISS (International Space Station) Space Medicine practice in the screening/assessment and management of CAD (Coronary Artery Disease) and to identify terrestrial applications for the general population pertaining to primary, secondary and tertiary diagnoses and treatments. We identified current Space Medicine practice for screening and monitoring cosmonaut and astronaut in the pre-, in-, and post-flight mission phases. We will discuss current Space Medicine standards and guidelines in the recognition and monitoring of CAD development, stabilization, and regression.

Johnston, Smith↗
DOE OSTI2016

Basic Research Needs for Innovation and Discovery of Transformative Experimental Tools

The scientific discoveries that expand the frontiers of human understanding, and that lead to the innovations of our technological world, require scientific tools and instrumentation to enable observation and manipulation of the physical world. As science advances, so too must its tools; the quest for deeper scientific insights and the drive to control chemistry and materials at the atomic and molecular levels require increasingly powerful and sophisticated instruments. A secure energy future requires technologies that use existing resources more efficiently, harness renewable resources, and efficiently store energy. The urgent demand for new energy technologies has ushered in a new era in scientific pursuit to decipher the complexity found at the core of chemical and materials processes, as articulated by the basic energy science research community in its series of Basic Research Needs (BRN) workshops. Historically, novel experimental tools and methods have been foundational in both scientific and technological advances — ranging from high-resolution microscopes that “see” atomic structures, to lithography that has enabled advances in semiconductors and computing. Today, expanding the frontiers of basic research requires new generations of instrumentation to reveal the intricacies of complex materials and chemical systems; energy systems in realistic working environments; and systems that are dynamical, far from equilibrium, and extremely heterogeneous. A concerted effort to invent, design, and build scientific instrumentation will enable new scientific breakthroughs and transformative technologies to address the most pressing energy challenges of the 21st century. To identify the highest priorities for the instrumentation innovation and development needed to address grand challenges in energy sciences, the U.S. Department of Energy’s Office of Basic Energy Sciences sponsored a workshop entitled, “Basic Research Needs for Innovation and Discovery of Transformative Experimental Tools” on June 1–3, 2016 near Washington, D.C. The workshop was attended by approximately 100 leading national and international scientific experts representing areas of basic energy sciences in chemistry, materials, physics, and biology, and included a mix of experimentalists and theorists.

46 INSTRUMENTATION RELATED TO NUCLEAR SCIENCE AND ↗
DOE OSTI2014

Final Technical Report. FG02-06ER54881

For over 25 years the Applied Superconductivity Center has been integral to the successful development of superconductors for magnetic confinement fusion reactors, culminating in being a part of the “dream team” assembled by the ITER Organization to address the failure of prototype ITER cable-in-conduit conductors to pass testing in the SULTAN facility, an issue that if not addressed successfully would have limited the useful lifetime of the reactor. While being called on through the years to address the immediate needs of facility construction we also continued fundamental studies of fusion applicable superconductors so that magnet designers could make use of improved performance, reliability and cost. The annual Low Temperature Superconductors workshops, jointly organized with LBNL, became the most important meeting for dissemination of data between university laboratories, national laboratories and industry.

2212↗
NASA NTRS1999

Tissue Engineered Skeletal Myofibers can Directly "Sense" Gravitational Force Changes

Long-term manned space flight requires a better understanding of skeletal muscle atrophy resulting from microgravity. Atrophy most likely results from changes at both the systemic level (e.g. decreased circulating growth hormone, increased circulating glucocorticoids) and locally (e.g. decreased myofiber resting tension). Differentiated skeletal myofibers in tissue culture have provided a model system over the last decade for gaining a better understanding of the interactions of exogenous growth factors, endogenous growth factors, and muscle fiber tension in regulating protein turnover rates and muscle cell growth. Tissue engineering these cells into three dimensional bioartificial muscle (BAM) constructs has allowed us to extend their use to Space flight studies for the potential future development of countermeasures. Embryonic avian muscle cells were isolated and BAMs tissue engineered as described previously. The myoblasts proliferate and fuse into aligned postmitotic myofibers after ten to fourteen days in vitro. A cylindrical muscle-like structure containing several thousand myofibers is formed which is approximately 30 mm in length, 2-3 mm in diameter, and attached at each end. For the Space Shuttle experiments, the BAMs were transferred to 55 mL bioreactor cartridges (6 BAMs/cartridge). At Kennedy Space Center, the cartridges were mounted in two Space Tissue Loss (STL) Modules (three to four cartridges per Module) and either maintained as ground controls or loaded in a Mid-Deck locker of the Space Shuttle. The BAM cartridges were continuously perfused during the experiment at 1.5 mL/ min with tissue culture medium. Eighteen BAMs were flown for nine days on Mission STS66 while eighteen BAMs served as ground controls. The complete experiment was repeated on Mission STS77 with twenty four BAMs in each group. BAMs could be maintained in a healthy state for at least 30 days in the perfusion bioreactor cartridges. The BAM muscle fibers directly detected both the loss of gravity and the reloading effects of 1 x g. While total cellular metabolism and total protein degradation rates were not altered during 9 to 10 days in Space, protein synthesis rates were significantly reduced and resulted in significant myofiber atrophy compared to ground controls. One g reloading of the flight muscle cells post-flight significantly increased protein synthesis rates and the synthesis rates of myosin heavy chain, fibronectin, and collagen. Tissue cultured muscle cells can directly "sense" changes in gravity and provide a valid model to begin the study of countermeasures. Based on our ground based experiments, and the experiments of others, growth hormone and/or insulin-like growth factors are attractive protein therapeutics which may assisting attenuating skeletal muscle wasting in space. Our laboratory is developing a new cell-based delivery system for this and other potential therapeutic factors for attenuating muscle and bone wasting.

Vandenburgh, Herman H.↗
NASA NTRS1996

Tissue-Engineered Skeletal Muscle Organoids for Reversible Gene Therapy

Genetically modified murine skeletal myoblasts were tissue engineered in vitro into organ-like structures (organoids) containing only postmitotic myoribers secreting pharmacological levels of recombinant human growth hormone (rhGH). Subcutaneous organoid implantation under tension led to the rapid and stable appearance of physiological sera levels of rhGH for up to 12 weeks, whereas surgical removal led to its rapid disappearance. Reversible delivery of bioactive compounds from postmitotic cells in tissue engineered organs has several advantages over other forms of muscle gene therapy.

Vandenburgh, Herman↗
NASA NTRS1996

Tissue-Engineered Skeletal Muscle Organoids for Reversible Gene Therapy

Genetically modified murine skeletal myoblasts were tissue engineered in vitro into organ-like structures (organoids) containing only postmitotic myofibers secreting pharmacological levels of recombinant human growth hormone (rhGH). Subcutaneous organoid Implantation under tension led to the rapid and stable appearance of physiological sera levels of rhGH for up to 12 weeks, whereas surgical removal led to its rapid disappearance. Reversible delivery of bioactive compounds from postimtotic cells in tissue engineered organs has several advantages over other forms of muscle gene therapy.

Vandenburgh, Herman↗